Shimamoto T, Kobayashi M, Numano F
Acta Pathol Jpn. 1975 Jan;25(1):51-67. doi: 10.1111/j.1440-1827.1975.tb00149.x.
Thepresence of IgG and beta-lipoprotein in thoracic and abdominal aortas of 33 rhesus monkeys under various conditions was observed by immunofluorescence and interference filter technique. In untreated and placebo control monkeys, a definite fluorescence due to IgG was seen in highly limited areas of the subendothelial space and the innermost layers and a weak but positive fluorescence due to beta-lipoprotein was sometimes show in highly limited spots of the subendothelial space, but not the medial layers. In challenged animals with cholesterol (1 g/kg p.o.) or epinephrine (1 mug/kg i.v.) or norepinephrine (10 mug/kg i.v.) or angiotensin II (1 mug/kg i.v.) or cholesterol (1 g/kg p.o.) plus epinephrine (1 mug/kg i.v.), definite fluorescence showing the entry of beta-lipoprotein and IgG from the vessel lumen into the subendothelial space and then into the medial layers of the arterial wall was clearly shown by serial sacrificing of animals after each challenge. The passage of beta-lipoprotein through the internal elastic lamina into the medial layer, was characteristically delayed as compared with that of IgG. In pretreated animals with pyridinolcarbamate (PDC) (10 mg/kg p.o.), EG467 (1 mg/kg p.o.) and Premarin (5 mg/kg i.v.), the acute entry of those plasma proteins was significantly inhibited.
采用免疫荧光和干涉滤光技术,观察了33只恒河猴在不同条件下胸主动脉和腹主动脉中IgG和β-脂蛋白的存在情况。在未经治疗的猴子和安慰剂对照猴子中,在内皮下间隙和最内层的高度局限区域可见因IgG产生的明确荧光,在内皮下间隙的高度局限部位有时可见因β-脂蛋白产生的微弱但阳性的荧光,但中膜层未见。在用胆固醇(口服1 g/kg)或肾上腺素(静脉注射1 μg/kg)或去甲肾上腺素(静脉注射10 μg/kg)或血管紧张素II(静脉注射1 μg/kg)或胆固醇(口服1 g/kg)加肾上腺素(静脉注射1 μg/kg)攻击的动物中,每次攻击后通过连续处死动物清楚地显示,有明确的荧光表明β-脂蛋白和IgG从血管腔进入内皮下间隙,然后进入动脉壁的中膜层。与IgG相比,β-脂蛋白穿过内弹性膜进入中膜层的过程明显延迟。在用吡啶醇胺(PDC)(口服10 mg/kg)、EG467(口服1 mg/kg)和妊马雌酮(静脉注射5 mg/kg)预处理的动物中,这些血浆蛋白的急性进入受到显著抑制。